References
Bines JE, Kohl KS, Forster J, et al; Brighton Collaboration Intussusception Working Group. Acute intussusception in infants and children as an adverse event following immunization; case definition and guidelines of data collection, analysis and presentation. Vaccine. 2004;22:569–74.
Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. Morb Mortal Wkly Rep. 1999;48:1007.
Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22.
Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. New Engl J Med. 2006;354:23–33.
World Health Organization. Meeting of the Strategic Advisory Group of Experts on Immunization, October 2009—conclusions and recommendations. Wkly Epidemiol Rec. 2009;84:517-32.
Carlin JB, Macartney KK, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s national immunisation program. Clin Infect Dis. 2013;57:1427–34.
Buttery JP, Danchin MH, Lee KJ, et al; PAEDS/APSU Study Group. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011;29:3061–6.
Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364:2283–92.
Velazquez FR, Colindres RE, Grajales C, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J. 2012;31:736–44.
Desai R, Parashar UD, Lopman B, et al. Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America. Clin Infect Dis. 2012;54:1397–405.
Haber P, Patel M, Pan Y, et al. Intussusception after rotavirus vaccines reported to US VAERS, 2006–2012. Pediatrics. 2013;131:1042–9.
John J, Kawade A, Rongsen-Chandola T, et al. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India. Vaccine. 2014;32:A104–9.
Kalaiselvan V, Thota P, Kumar V, Rathore MS, Thota A, Singh GN. Risk of intussusception with rotavirus vaccine. Indian J Pediatr. 2016. doi:10.1007/s12098-016-2230-z.
Rota virus vaccine. WHO position paper. January 2013- recommendations. Vaccine. 2013;31:6170–1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
None.
Rights and permissions
About this article
Cite this article
Dutta, A.K. Rotavirus Vaccination in India – Need for Surveillance of Intussusception. Indian J Pediatr 84, 95–96 (2017). https://doi.org/10.1007/s12098-016-2245-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-016-2245-5